Compare FENG & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENG | MODD |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 33.0M |
| IPO Year | 2011 | N/A |
| Metric | FENG | MODD |
|---|---|---|
| Price | $2.03 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.5K | ★ 495.2K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,947,410.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.17 | N/A |
| 52 Week Low | $1.28 | $0.28 |
| 52 Week High | $3.65 | $1.68 |
| Indicator | FENG | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 34.88 |
| Support Level | $2.01 | $0.30 |
| Resistance Level | $2.08 | $0.47 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 13.33 | 35.06 |
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.